Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs (Q39669606)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 June 2016

Language	Label	Description	Also known as
English	Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs	scientific article published on 20 June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs (English)

1 reference

Europe PubMed Central

13 September 2017

rheumatoid arthritis

0 references

27

object named as

Georg Schett

1 reference

Europe PubMed Central

13 September 2017

Hans-Peter Tony

11

object named as

Hans-Peter Tony

1 reference

Europe PubMed Central

13 September 2017

Hanns-Martin Lorenz

21

object named as

Hanns-Martin Lorenz

1 reference

Europe PubMed Central

13 September 2017

author name string

Camille P Figueiredo

1

1 reference

Europe PubMed Central

13 September 2017

Holger Bang

2

1 reference

Europe PubMed Central

13 September 2017

Jayme Fogagnolo Cobra

3

1 reference

Europe PubMed Central

13 September 2017

Matthias Englbrecht

4

1 reference

Europe PubMed Central

13 September 2017

Axel J Hueber

5

1 reference

Europe PubMed Central

13 September 2017

Judith Haschka

6

1 reference

Europe PubMed Central

13 September 2017

Bernhard Manger

7

1 reference

Europe PubMed Central

13 September 2017

Arnd Kleyer

8

1 reference

Europe PubMed Central

13 September 2017

Michaela Reiser

9

1 reference

Europe PubMed Central

13 September 2017

Stephanie Finzel

10

1 reference

Europe PubMed Central

13 September 2017

Stefan Kleinert

12

1 reference

Europe PubMed Central

13 September 2017

Joerg Wendler

13

1 reference

Europe PubMed Central

13 September 2017

Florian Schuch

14

1 reference

Europe PubMed Central

13 September 2017

Monika Ronneberger

15

1 reference

Europe PubMed Central

13 September 2017

Martin Feuchtenberger

16

1 reference

Europe PubMed Central

13 September 2017

Martin Fleck

17

1 reference

Europe PubMed Central

13 September 2017

Karin Manger

18

1 reference

Europe PubMed Central

13 September 2017

Wolfgang Ochs

19

1 reference

Europe PubMed Central

13 September 2017

Matthias Schmitt-Haendle

20

1 reference

Europe PubMed Central

13 September 2017

Hubert Nuesslein

22

1 reference

Europe PubMed Central

13 September 2017

Rieke Alten

23

1 reference

Europe PubMed Central

13 September 2017

Joerg Henes

24

1 reference

Europe PubMed Central

13 September 2017

Klaus Krueger

25

1 reference

Europe PubMed Central

13 September 2017

Jürgen Rech

26

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

20 June 2016

1 reference

Europe PubMed Central

13 September 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

13 September 2017

76

1 reference

Europe PubMed Central

13 September 2017

399-407

1 reference

Europe PubMed Central

13 September 2017

2

1 reference

Europe PubMed Central

13 September 2017

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Treating rheumatoid arthritis to target: recommendations of an international task force

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

When to initiate and discontinue biologic treatments for rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Sustained remission with etanercept tapering in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Autoantibodies to citrullinated proteins: ACPA.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Immunity to citrullinated proteins in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Autoimmunity in rheumatoid arthritis: different antigens--common principles

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Tissue-specific sequence and structural environments of lysine acetylation sites.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Lysine acetylation: codified crosstalk with other posttranslational modifications

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Acetylation and deacetylation of non-histone proteins

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Regulation of cellular metabolism by protein lysine acetylation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic mice

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Comprehensive lysine acetylomes emerging from bacteria to humans

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Antihomocitrullinated Fibrinogen Antibodies are Specific to Rheumatoid Arthritis and Frequently Bind Citrullinated Proteins/peptides

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2016-209297

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2016-209297

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39669606&oldid=2138371213"